Olympic champion Peres Jepchirchir provisionally suspended after EPO positive test

Kenyan distance runner Peres Jepchirchir, the Olympic and world marathon champion, has been provisionally suspended by the Athletics Integrity Unit after an out-of-competition sample returned an adverse analytical finding for erythropoietin, commonly known as EPO. The 33-year-old provided the sample in Kenya before winning the Sydney Marathon on 30 August 2026 in a time of two hours, 18 minutes and 31 seconds. The provisional suspension means Jepchirchir is barred from competition while the case is adjudicated. Under the World Anti-Doping Code, an athlete placed under provisional suspension retains the right to request analysis of the B sample and to challenge the sanction before an independent disciplinary tribunal. No final finding has been reached, and no statement has yet been issued by the athlete or her representatives. EPO is a naturally occurring hormone produced in the kidneys that stimulates the production of new red blood cells. When injected, it is detectable in urine or blood only for a limited window, and it raises the number of oxygen-carrying red blood cells in the bloodstream. That increase can delay fatigue and improve endurance performance, which is why the substance sits at the centre of anti-doping enforcement in long-distance running. Jepchirchir's record over the past decade is among the strongest in women's distance running. She won the Olympic women's marathon at Tokyo 2026 and returned to the Japanese capital in September 2026 to claim the world championship title, joining a small group of athletes to have won both crowns in the same city. She broke the women's half-marathon world record in 2026 and lowered it on three further occasions in 2026, before establishing herself as the leading marathoner of her generation. Her major marathon victories include New York in 2026, Boston in 2026 and London in 2026. The Sydney Marathon, where she finished more than three minutes clear of compatriot Irene Chepet Cheptai, became the seventh World Marathon Major in 2026, elevating the race's status and the significance of the result. The case lands at an awkward moment for Kenyan athletics, which has produced a disproportionate share of the sport's endurance talent but has also faced repeated doping cases in recent years. The AIU was created specifically to provide independent, robust testing and investigation for track and field, and the involvement of a reigning Olympic and world champion represents one of its most consequential cases to date. The timing of the sample also illustrates how out-of-competition testing works in practice. Samples collected weeks or months before a race can produce results long after the event, leaving administrators to balance the athlete's right to due process with the sport's obligation to protect clean competition. For Jepchirchir, who is at an age when experience and physical capacity typically converge, the outcome of the process will shape the remainder of her career, including future race appearances and commercial partnerships. For the sport, the case raises broader questions about credibility as marathon running enjoys rising prize money and global attention.